CD8 PET to stop or switch immunotherapy early
Scan for T cells inside the tumour a few weeks after starting immunotherapy. If they have not arrived, change course.
89Zr-crefmirlimab (CD8 minibody) and 18F-AraG image T-cell infiltration and activation. Early increase correlates with response in phase 2 studies.
Pages like this
not linked directly; found by shared links- PersonTasuku Honjo
Shares No one can predict who responds to immunotherapy, PD-1, Melanoma, Immune checkpoint inhibitors.
- IdeaRandomise a cheap antihistamine alongside immunotherapy
Shares No one can predict who responds to immunotherapy, Melanoma, Immune checkpoint inhibitors, Non-small-cell lung cancer.
- InstitutionOlivia Newton-John Cancer Wellness and Research Centre
Shares Immuno-PET, Melanoma, Immune checkpoint inhibitors.
- IdeaTest protein and resistance training during immunotherapy
Shares No one can predict who responds to immunotherapy, Melanoma, Immune checkpoint inhibitors, Non-small-cell lung cancer.
- IdeaTreat immunotherapy side-effects without wiping out the response
Shares No one can predict who responds to immunotherapy, Melanoma, Immune checkpoint inhibitors, Non-small-cell lung cancer.
- IdeaRandomised trials of stopping immunotherapy after one year versus continuing
Shares PD-1, Melanoma, Immune checkpoint inhibitors, Non-small-cell lung cancer.
- PersonSuzanne L. Topalian
Shares PD-1, Melanoma, Immune checkpoint inhibitors, Non-small-cell lung cancer.
- InstitutionCentre hospitalier de l'Université de Montréal (CHUM)
Shares No one can predict who responds to immunotherapy, Melanoma, Immune checkpoint inhibitors, Non-small-cell lung cancer.